839 related articles for article (PubMed ID: 29306180)
1. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
[TBL] [Abstract][Full Text] [Related]
2. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
3. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
Gynecol Endocrinol; 2014 Jul; 30(7):490-3. PubMed ID: 24641676
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
5. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
[TBL] [Abstract][Full Text] [Related]
6. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest.
Alson SSE; Bungum LJ; Giwercman A; Henic E
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():199-204. PubMed ID: 29738982
[TBL] [Abstract][Full Text] [Related]
7. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
[TBL] [Abstract][Full Text] [Related]
8. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
9. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth.
Nelson SM; Fleming R; Gaudoin M; Choi B; Santo-Domingo K; Yao M
Fertil Steril; 2015 Aug; 104(2):325-32. PubMed ID: 26003269
[TBL] [Abstract][Full Text] [Related]
10. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
11. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antral follicle count and serum anti Müllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial.
Li HWR; Ko JKY; Lee VCY; Yung SSF; Lau EYL; Yeung WSB; Ho PC; Ng EHY
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):303-309. PubMed ID: 31325336
[TBL] [Abstract][Full Text] [Related]
14. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
15. AFC vs. AMH: prediction of ovarian response in women with endometrioma undergoing controlled ovarian stimulation.
Ersahin AA; Arpaci H; Ersahin SS; Celik N; Acet M
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2499-2503. PubMed ID: 28617534
[TBL] [Abstract][Full Text] [Related]
16. Hormonal and functional biomarkers in ovarian response.
Vural B; Cakiroglu Y; Vural F; Filiz S
Arch Gynecol Obstet; 2014 Jun; 289(6):1355-61. PubMed ID: 24366586
[TBL] [Abstract][Full Text] [Related]
17. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.
Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
PLoS One; 2013; 8(4):e61095. PubMed ID: 23637787
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
19. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.
Kotanidis L; Nikolettos K; Petousis S; Asimakopoulos B; Chatzimitrou E; Kolios G; Nikolettos N
J Endocrinol Invest; 2016 Dec; 39(12):1459-1464. PubMed ID: 27465668
[TBL] [Abstract][Full Text] [Related]
20. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]